Literature DB >> 3308988

CT findings in hepatosplenic and renal candidiasis.

A Shirkhoda1.   

Abstract

Fourteen patients with the diagnosis of leukemia and one with lymphoma developed systemic candidiasis. Involvement of the liver (15 patients), spleen (nine patients), and kidney (five patients) was diagnosed by clinical, CT, and pathologic findings. The CT findings ranged from low-density lesions (11 livers, nine spleens, and five kidneys) to hepatomegaly or hepatosplenomegaly. All livers and three kidneys had positive biopsy findings for Candida. Two patients with diffuse splenic lesions underwent splenectomy and were proven to have candidiasis. During a 1 year follow-up, two patients developed hepatic calcifications and one developed renal calcifications. In proper clinical setting, CT should be done for simultaneous evaluation of the liver, spleen, and kidneys. These studies, when positive, are useful to guide percutaneous or open biopsy and to follow the results of therapy. However, regardless of the hepatic CT finding, biopsy should be obtained to establish the diagnosis and begin proper treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308988     DOI: 10.1097/00004728-198709000-00010

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  4 in total

1.  Hepatitis and a rash in an immunocompromised patient.

Authors:  V Shah; A Saini
Journal:  Br J Radiol       Date:  2011-02       Impact factor: 3.039

2.  Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignancies.

Authors:  M von Eiff; M Essink; N Roos; W Hiddemann; T Büchner; J van de Loo
Journal:  Blut       Date:  1990-04

3.  Pediatric renal leukemia: spectrum of CT imaging findings.

Authors:  Melissa A Hilmes; Jonathan R Dillman; Rajen J Mody; Peter J Strouse
Journal:  Pediatr Radiol       Date:  2008-02-01

4.  Clinical feature, image findings and outcome of hepatosplenic candidiasis in patients with acute myeloid leukemia.

Authors:  Hung Chang; Ming-Chung Kuo; Tzung-Chih Tang; Tung-Liang Lin; Jin-Hou Wu
Journal:  Biomed J       Date:  2020-11-18       Impact factor: 7.892

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.